NEOSTIGMINE METHYLSULFATE
NDC 42023-188, NEOSTIGMINE METHYLSULFATE, injection, from Par Health USA, LLC.
- Product NDC
- 42023-188
- Status
- Listed
- Labeler
- Par Health USA, LLC
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208405
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/42023-188 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NEOSTIGMINE METHYLSULFATE.5 mg/mL
Pharmacologic classes
Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42023-188-10 | 42023018810 | 10 VIAL, MULTI-DOSE in 1 CARTON (42023-188-10) / 10 mL in 1 VIAL, MULTI-DOSE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/673140f7-273e-4543-98b5-6b12c59f540b
Use it
Look up 42023-188 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42023-188 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42023-188. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.